ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1024

Time Trends in the Incidence of Systemic Lupus Erythematosus: A 40-Year Study

Ali Duarte-Garcia1, Mehmet Hocaoglu2, Shirley-Ann Osei-Onomah3, Jesse Dabit1, Rachel Giblon1 and Cynthia Crowson4, 1Mayo Clinic, Rochester, MN, 2University of Maryland Medical Center Midtown Campus, Baltimore, MD, 3Mayo Clinic, Rochester, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

Meeting: ACR Convergence 2020

Keywords: Epidemiology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Changes over time in the incidence of Systemic Lupus Erythematosus (SLE) remain uncertain. It is unclear if the variations in established SLE risk factors, such as the decline in smoking over time  or the trend towards use of low-dose oral contraceptives, has had an impact in SLE incidence. We aimed to investigate secular trends in the incidence of SLE in adults from 1976-2018.

Methods:

Using established population-based research infrastructure that links the medical records of all the individuals in a geographically well-defined population, we identified all the incident SLE cases from 1976-2018 using diagnostic codes for cutaneous and systemic lupus and the following laboratory measures: anti-nuclear antibodies, anti-double stranded DNA, anti-Sm, anti-cardiolipin, anti-beta 2 glycoprotein 1 antibodies, complement, coombs and lupus anticoagulant. After an extensive medical record review, cases were classified based on the 1982 or 1997 American College of Rheumatology classification criteria, and we considered the date of meeting classification as the incidence date. Incidence rates were age‐ and/or sex‐adjusted to the estimated 2010 white population of the US. To compute 95% confidence intervals for incidence rates, it was assumed that the number of incident cases followed a Poisson distribution.

Results: We identified 152 incident SLE cases between the years 1976 and 2018. As detailed in Table 1, the mean age was 46.3 years (SD16.4), 84% were female. The racial distribution was 5% Black, 12% Asian, 82% Caucasian while 5% were Hispanic.

The overall SLE incidence was 3.9 (95%CI: 3.2, 4.5) per 100,000. The incidence rate in females was 6.2 (95%CI: 5.1, 7.3) while in males was 1.6 (95%CI: 0.9, 2.2) per 100,000. Age- and sex- specific incidence peaked at 40-49 years for females. In males there was an upward trend in the incidence after age 50. There was an increase over the years in the proportion of incident SLE cases in minorities.

The incidence of SLE increased 29% from 3.5 (95%CI: 2.1, 4.9) in 1976-1988 to 4.5 (95%CI: 3.3, 5.7) in 2009-2018 per 100,000 (Table 2). This increase in incidence was more pronounced in males with an increase of 0.9 to 2 per 100,000. The incidence of SLE seemed to have a 10-year cyclical pattern (figure 1). 

Conclusion: Our 40-year population-based study suggests that the SLE incidence in adults had an overall 29% increase and has doubled in males over the last four decades. SLE has a cyclical pattern similar to other autoimmune diseases. It’s unclear if the increase in incidence is due to improvement in awareness and detection of SLE, changes in the racial make-up of the population, changes in lupus-related risk factors or a combination thereof.

Trends in age- adjusted systemic lupus erythematosus from 1976-2018

Table 1. Demographics

Table 2 Incidence rates of systemic lupus erythematosus from 1976-2018


Disclosure: A. Duarte-Garcia, None; M. Hocaoglu, None; S. Osei-Onomah, None; J. Dabit, None; R. Giblon, None; C. Crowson, Myriad Genetics, 1, Pfizer, 1.

To cite this abstract in AMA style:

Duarte-Garcia A, Hocaoglu M, Osei-Onomah S, Dabit J, Giblon R, Crowson C. Time Trends in the Incidence of Systemic Lupus Erythematosus: A 40-Year Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/time-trends-in-the-incidence-of-systemic-lupus-erythematosus-a-40-year-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/time-trends-in-the-incidence-of-systemic-lupus-erythematosus-a-40-year-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology